Increased tumor-associated mast cells facilitate thyroid cancer progression by inhibiting CD8+ T cell function through galectin-9
暂无分享,去创建一个
[1] G. Marone,et al. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment , 2019, International journal of molecular sciences.
[2] G. Sammarco,et al. Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer , 2019, International journal of molecular sciences.
[3] R. Melillo,et al. Recent advances in understanding immune phenotypes of thyroid carcinomas: prognostication and emerging therapies , 2019, F1000Research.
[4] Y. Zhuang,et al. Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway , 2019, Journal of Immunotherapy for Cancer.
[5] G. Sammarco,et al. Tumor-Associated Macrophages and Mast Cells Positive to Tryptase Are Correlated with Angiogenesis in Surgically-Treated Gastric Cancer Patients , 2018, International journal of molecular sciences.
[6] Shimin Wang,et al. Tumor‐infiltrating tryptase+ mast cells predict unfavorable clinical outcome in solid tumors , 2018, International journal of cancer.
[7] A. Mantovani,et al. Mast Cell–Dependent CD8+ T-cell Recruitment Mediates Immune Surveillance of Intestinal Tumors in ApcMin/+ Mice , 2018, Cancer Immunology Research.
[8] F. Granata,et al. Are Mast Cells MASTers in Cancer? , 2017, Front. Immunol..
[9] S. Devesa,et al. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013 , 2017, JAMA.
[10] S. Nonogaki,et al. CD8+ tumour‐infiltrating lymphocytes and COX2 expression may predict relapse in differentiated thyroid cancer , 2015, Clinical endocrinology.
[11] V. Aidinis,et al. Mast cells mediate malignant pleural effusion formation. , 2015, The Journal of clinical investigation.
[12] Florian Klemm,et al. Microenvironmental regulation of therapeutic response in cancer. , 2015, Trends in cell biology.
[13] R. Franco,et al. Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8–Akt–Slug pathway , 2015, Oncogene.
[14] M. Luster,et al. Differentiated thyroid cancer—personalized therapies to prevent overtreatment , 2014, Nature Reviews Endocrinology.
[15] Z. Illés,et al. Peripheral Blood TIM-3 Positive NK and CD8+ T Cells throughout Pregnancy: TIM-3/Galectin-9 Interaction and Its Possible Role during Pregnancy , 2014, PloS one.
[16] S. Pileri,et al. Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma. , 2014, Blood.
[17] Stephen J Galli,et al. Mast Cells: Potential Positive and Negative Roles in Tumor Biology , 2013, Cancer Immunology Research.
[18] S. Nonogaki,et al. Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma , 2012, Clinical endocrinology.
[19] R. Stan,et al. Mast cells impair the development of protective anti-tumor immunity , 2012, Cancer Immunology, Immunotherapy.
[20] Stephen J Galli,et al. IgE and mast cells in allergic disease , 2012, Nature Medicine.
[21] R. McIntyre,et al. Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer. , 2012, The Journal of clinical endocrinology and metabolism.
[22] R. Schreiber,et al. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.
[23] M. Santoro,et al. Mast cells have a protumorigenic role in human thyroid cancer , 2010, Oncogene.
[24] D. Ingber,et al. Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] H. Xiong,et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. , 2008, Blood.
[26] T. Niki,et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. , 2008, Clinical immunology.
[27] V. Kuchroo,et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity , 2005, Nature Immunology.
[28] M. J. Abedin,et al. Possible role of galectin‐9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance , 2002, International journal of cancer.
[29] T. Carling,et al. Thyroid cancer. , 2014, Annual review of medicine.